Poseida Therapeutics Ownership | Who Owns Poseida Therapeutics?
Poseida Therapeutics Ownership Summary
Poseida Therapeutics is owned by 31.47% institutional investors, 27.64% insiders, and 40.89% retail investors. Blackrock is the largest institutional shareholder, holding 5.11% of PSTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.65% of its assets in Poseida Therapeutics shares.
PSTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Poseida Therapeutics | 31.47% | 27.64% | 40.89% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 4.91M | 5.11% | $14.32M |
| Boxer capital | 4.47M | 4.66% | $13.07M |
| State street | 1.59M | 1.64% | $15.31M |
| Jacobs levy equity management | 927.01K | 0.97% | $2.71M |
| Acadian asset management | 933.10K | 0.96% | $8.96M |
| Morgan stanley | 363.28K | 0.38% | $1.06M |
| Nuveen asset management | 299.30K | 0.31% | $2.87M |
| Renaissance | 271.20K | 0.28% | $2.60M |
| Susquehanna group, llp | 198.38K | 0.20% | $1.90M |
| Strs ohio | 124.30K | 0.13% | $362.96K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital | 4.47M | 0.69% | $13.07M |
| Acadian asset management | 933.10K | 0.03% | $8.96M |
| Jacobs levy equity management | 927.01K | 0.01% | $2.71M |
| Renaissance | 271.20K | 0.00% | $2.60M |
| Intech investment management | 21.97K | 0.00% | $210.91K |
| Dekabank deutsche girozentrale | 100.00K | 0.00% | $913.00K |
| Strs ohio | 124.30K | 0.00% | $362.96K |
| Nuveen asset management | 299.30K | 0.00% | $2.87M |
| Public employees retirement system of ohio | 59.35K | 0.00% | $173.31K |
| State street | 1.59M | 0.00% | $15.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Susquehanna group, llp | 198.38K | 0.00% | 198.38K |
| Acadian asset management | 933.10K | 0.03% | 102.06K |
| Jacobs levy equity management | 927.01K | 0.01% | 96.88K |
| Strs ohio | 124.30K | 0.00% | 12.70K |
| Wells fargo & company/mn | 37.95K | 0.00% | 6.87K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | - | - | -10.01M |
| Pentwater capital management lp | - | - | -8.63M |
| Blackrock funding, inc. /de | - | - | -5.63M |
| Nomura | - | - | -5.12M |
| Vanguard group | - | - | -3.83M |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -1.00 |
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Us bancorp \de\ | -26.00 |
| Allspring global investments | -34.00 |
| Srs capital advisors | -38.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 68 | -30.61% | 30,574,325 | -42.86% | 31 | 1.04% | 46 | -13.21% | 12 | -42.86% |
| Sep 30, 2024 | 97 | 3.19% | 53,501,171 | 1.05% | 55 | 1.81% | 53 | - | 21 | - |
| Jun 30, 2024 | 94 | 1.08% | 52,945,375 | 0.40% | 55 | 1.61% | 53 | 6.00% | 21 | -8.70% |
| Mar 31, 2024 | 93 | 3.33% | 52,736,698 | 16.63% | 58 | 2.42% | 50 | 4.17% | 23 | -4.17% |
| Dec 31, 2023 | 90 | 2.27% | 45,216,197 | 0.03% | 49 | 1.81% | 48 | 17.07% | 24 | 9.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 4.54M | 4.65% | 49.24K |
| Fidelity Growth Compy Commingled Pl O | 4.41M | 4.54% | 12.03K |
| Fidelity Growth Company Fund | 3.41M | 3.49% | -69.66K |
| Fidelity Select Health Care | 2.39M | 2.45% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.19M | 2.24% | 47.66K |
| iShares Russell 2000 ETF | 1.82M | 1.86% | -6.97K |
| Fidelity Advisor Health Care I | 1.45M | 1.49% | - |
| Fidelity Growth Company K6 | 1.21M | 1.24% | -26.18K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.09M | 1.12% | 96.97K |
| Fidelity Series Growth Company | 858.56K | 0.88% | -67.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | Gergen Mark J | Executive Chairman | Sell | $283.87K |
| Nov 26, 2024 | Gergen Mark J | Executive Chairman | Sell | $278.10K |
| Aug 08, 2022 | Malin Life Sciences Holdings Ltd | Buy | $7.53M | |
| Aug 08, 2022 | Ostertag Eric | Executive Chairman | Buy | $500.00K |
| Aug 03, 2022 | Ostertag Eric | Executive Chairman | Sell | $592.81K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | 2 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
PSTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools